Leo H. Evart Inc. acquired a new position in UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 802 shares of the healthcare conglomerate’s stock, valued at approximately $ 403,000. UnitedHealth Group accounts for approximately 0.4% of Leo H. Evart Inc.’s portfolio, making its stock its 29th largest holding.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Outfitter Financial LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $ 25,000. Blue Bell Private Wealth Management LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $ 29,000. Tortoise Investment Management LLC grew its holdings in UnitedHealth Group by 54.8% during the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $ 33,000 after purchasing an additional 23 shares during the period. Leverty Financial Group LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $ 34,000. Finally, Stuart Chaussee & Associates Inc. grew its holdings in UnitedHealth Group by 55.6% during the fourth quarter. Stuart Chaussee & Associates Inc. now owns 70 shares of the healthcare conglomerate’s stock valued at $ 35,000 after purchasing an additional 25 shares during the period. 87.48% of the stock is owned by institutional investors.
In other UnitedHealth Group news, Director Richard T. Burke sold 3,000 shares of the company stock in a transaction on Thursday, March 24th. The stock was sold at an average price of $ 508.80, for a total transaction of $ 1,526,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 4,000 shares of the company stock in a transaction on Tuesday, March 22nd. The stock was sold at an average price of $ 511.14, for a total value of $ 2,044,560.00. The disclosure for this sale can be found here. In the last three months, insiders sold 12,000 shares of company stock worth $ 6,001,485. 0.40% of the stock is owned by insiders.
UNH opened at $ 452.06 on Friday. The stock has a market cap of $ 424.11 billion, a price-to-earnings ratio of 24.74, a P / E / G ratio of 1.42 and a beta of 0.83. The stock’s 50 day moving average price is $ 500.28 and its 200-day moving average price is $ 490.61. UnitedHealth Group Incorporated has a one year low of $ 383.12 and a one year high of $ 553.29. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78.
UnitedHealth Group (NYSE: UNH – Get Rating) last released its earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 EPS for the quarter, beating analysts’ consensus estimates of $ 5.40 by $ 0.09. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The firm had revenue of $ 80.15 billion for the quarter, compared to analysts’ expectations of $ 78.77 billion. During the same quarter in the prior year, the firm posted $ 5.31 earnings per share. The company quarterly revenue was up 14.2% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be paid a $ 1.65 dividend. The ex-dividend date of this dividend is Thursday, June 16th. This represents a $ 6.60 annualized dividend and a yield of 1.46%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $ 1.45. UnitedHealth Group’s dividend payout ratio is 36.12%.
Several analysts have issued reports on UNH shares. Raymond James boosted their price target on UnitedHealth Group from $ 540.00 to $ 620.00 and gave the company a “strong-buy” rating in a report on Tuesday, April 19th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $ 482.00 to $ 549.00 and gave the company a “buy” rating in a research report on Monday, April 18th. Barclays boosted their price target on UnitedHealth Group from $ 495.00 to $ 565.00 and gave the company an “overweight” rating in a research report on Wednesday, March 30th. BMO Capital Markets boosted their price target on UnitedHealth Group from $ 510.00 to $ 600.00 and gave the company a “market perform” rating in a research report on Tuesday, April 19th. Finally, Cowen boosted their price target on UnitedHealth Group from $ 512.00 to $ 596.00 in a research report on Monday, April 18th. Three research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $ 555.73.
UnitedHealth Group Company Profile: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE: UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.